デフォルト表紙
市場調査レポート
商品コード
1509640

消化管病原体検査の世界市場レポート 2024年

Gastrointestinal Pathogen Testing Global Market Report 2024

出版日: | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.78円
消化管病原体検査の世界市場レポート 2024年
出版日: 2024年07月08日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

消化管病原体検査の市場規模は、今後数年間で安定した成長が見込まれます。2028年にはCAGR4.4%で48億米ドルに成長します。予測期間中に予想される成長は、世界の消化器感染症の流行増加、早期発見・治療の重要性に対する意識の高まり、新興経済諸国におけるヘルスケアインフラの拡大、ポイントオブケア検査ソリューションに対する需要の高まり、食品安全規制への注目の高まり、継続的な研究開発努力など、いくつかの要因によるものと考えられます。この期間に予想される主な動向には、迅速検査法の採用、分子診断技術の利用拡大、従来とは異なる医療環境におけるポイントオブケア検査の拡大、検査プロセスを合理化するための自動化とロボット工学の進歩、病原体検出を強化するための新規バイオマーカーの出現、診断プロセスへの人工知能と機械学習アルゴリズムの統合などがあります。

食中毒の増加により、消化管病原体検査市場は当面拡大する見通しです。食中毒には、リステリア症、ウイルス性胃腸炎、テニア症、トリインフルエンザなどの病気を含め、有害な微生物、毒素、化学物質で汚染された食品や飲料の摂取に起因する病気が含まれます。食中毒の急増は、食品生産、流通、消費慣行の変化、不十分な食品安全プロトコル、気候変動が食品生産に及ぼす影響など、さまざまな要因に起因しています。胃腸検査は、食中毒の原因となる特定の病原体を特定し、医療従事者が胃腸症状を診断し、適切な治療方法を決定し、発生を監視し、食中毒の蔓延を緩和するための予防措置を実施する上で重要な役割を果たします。例えば、2024年2月の英国健康安全保障庁(UK Health Security Agency)のデータでは、イングランドとウェールズにおけるリステリア症の症例が増加しており、2021年の160症例に対して2022年には167症例が報告されていることが明らかになっており、消化管病原体検査の重要性が高まっていることが強調されています。

消化管病原体検査市場の主なプレーヤーは、消化管病原体検出の精度、スピード、網羅性を高めるために、メタゲノム診断検査などの最先端ソリューションの開拓に力を注いでいます。メタゲノム診断検査は、便や血液などのサンプル中に存在する微生物の遺伝物質を分析するために利用される先端技術です。例えば、オーストラリアを拠点とするバイオテクノロジー企業、Microba Life Sciences社は、2024年4月にMetaPanelを発表しました。MetaPanelは、広範な消化管病原体をこれまでにない精度で同定するために開発されたメタゲノム診断検査です。MetaPanelは、単一の検査で175の病原体ターゲットを網羅し、一般的な感染症から課題となっている感染症まで診断できる包括的なツールをヘルスケア従事者に提供します。次世代シーケンス(NGS)テクノロジーを活用することで、MetaPanelは便サンプル中の多様な遺伝物質を分析し、従来の消化管パネルではルーチンに評価されなかったものも含め、様々な潜在的病原体の検出を可能にします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の消化管病原体検査市場:促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の消化管病原体検査市場の実績:規模と成長, 2018-2023
  • 世界の消化管病原体検査市場の予測:規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

  • 世界の消化管病原体検査市場:病原体タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 細菌
  • ウイルス
  • 寄生虫
  • 世界の消化管病原体検査市場:検査タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 分子検査
  • 培養
  • 生化学検査
  • その他の検査タイプ
  • 世界の消化管病原体検査市場:パネルタイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 症候群フルマルチプレックスパネル
  • その他のパネルタイプ
  • 世界の消化管病原体検査市場:エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 病院
  • 診断ラボ
  • ポイントオブケア
  • その他のエンドユーザー

第7章 地域別・国別分析

  • 世界の消化管病原体検査市場:地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界の消化管病原体検査市場:国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 消化管病原体検査市場:競合情勢
  • 消化管病原体検査市場:企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd
    • Becton Dickinson and Company
    • Hologic Inc.

第31章 その他の大手企業と革新的企業

  • bioMerieux S.A.
  • Bio-Rad Laboratories Inc.
  • QIAGEN N.V.
  • DiaSorin S.p.A.
  • Cepheid Inc.
  • OraSure Technologies Inc.
  • BioFire Diagnostics Inc.
  • Luminex Corporation
  • Meridian Bioscience Inc.
  • Sekisui Diagnostics LLC
  • ELITechGroup S.A.S.
  • Hardy Diagnostics LLC
  • Trinity Biotech plc
  • Puritan Medical Products Co. LLC
  • Cosmo Bio Co. Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r18137

Gastrointestinal pathogen testing refers to the diagnostic process aimed at identifying infections and diseases resulting from various pathogens affecting the digestive tract, which includes the stomach and intestines. This involves analyzing specimens such as stool or blood to identify the specific pathogens responsible for gastrointestinal symptoms, enabling accurate diagnosis and treatment of gastrointestinal disorders.

The primary types of pathogens targeted in gastrointestinal pathogen testing include bacteria, viruses, and parasites, all of which can cause illness in the digestive system. Various testing methods are employed, including molecular tests, culture techniques, biochemical assays, and others, with different panel types available, such as syndromic full multiplex panels and others. These testing services cater to a range of end-users, including hospitals, diagnostic laboratories, point-of-care facilities, and others.

The gastrointestinal pathogen testing market research report is one of a series of new reports from The Business Research Company that provides gastrointestinal pathogen testing market statistics, including gastrointestinal pathogen testing industry global market size, regional shares, competitors with a gastrointestinal pathogen testing market share, detailed gastrointestinal pathogen testing market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal pathogen testing industry. This gastrointestinal pathogen testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastrointestinal pathogen testing market size has grown steadily in recent years. It will grow from $3.89 billion in 2023 to $4.05 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth observed during the historic period can be attributed to several factors, including the increased prevalence of gastrointestinal infections, heightened awareness about foodborne illnesses, globalization resulting in higher rates of travel-related infections, regulatory efforts to ensure food safety, an increase in healthcare expenditure, and a growing demand for rapid and accurate diagnostic solutions.

The gastrointestinal pathogen testing market size is expected to see steady growth in the next few years. It will grow to $4.80 billion in 2028 at a compound annual growth rate (CAGR) of 4.4%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing prevalence of gastrointestinal infections globally, growing awareness about the importance of early detection and treatment, expansion of healthcare infrastructure in emerging economies, rising demand for point-of-care testing solutions, heightened focus on food safety regulations, and continuous research and development efforts. Major trends expected during this period include the adoption of rapid testing methods, growing utilization of molecular diagnostic techniques, expansion of point-of-care testing in non-traditional healthcare settings, advancements in automation and robotics for streamlined testing processes, the emergence of novel biomarkers for enhanced pathogen detection, and integration of artificial intelligence and machine learning algorithms into diagnostic processes.

The increasing occurrences of foodborne illnesses are poised to drive the expansion of the gastrointestinal pathogen testing market in the foreseeable future. Foodborne diseases encompass illnesses resulting from the consumption of food or beverages contaminated with harmful microorganisms, toxins, or chemical substances, including ailments such as listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The upsurge in foodborne incidents can be attributed to various factors such as shifts in food production, distribution, and consumption practices, inadequate food safety protocols, and the impacts of climate change on food production. Gastrointestinal testing plays a crucial role in identifying the specific pathogens responsible for foodborne illnesses, aiding healthcare providers in diagnosing gastrointestinal symptoms, determining suitable treatment approaches, monitoring outbreaks, and implementing preventive measures to mitigate the spread of foodborne diseases. For instance, data from the UK Health Security Agency in February 2024 revealed an increase in listeriosis cases in England and Wales, with 167 reported cases in 2022 compared to 160 cases in 2021, underscoring the growing significance of gastrointestinal pathogen testing.

Key players in the gastrointestinal pathogen testing market are directing their efforts towards developing cutting-edge solutions, such as metagenomic diagnostic tests, to enhance the precision, speed, and comprehensiveness of gastrointestinal pathogen detection. Metagenomic diagnostic tests represent advanced technologies utilized for analyzing the genetic material of microorganisms present in samples such as stool or blood. For example, Microba Life Sciences, an Australia-based biotechnology company, introduced MetaPanel in April 2024-a metagenomic diagnostic test engineered to identify a broad spectrum of gastrointestinal pathogens with unprecedented accuracy. MetaPanel encompasses 175 pathogen targets within a single test, offering healthcare practitioners a comprehensive tool for diagnosing both common and challenging infections. Leveraging next-generation sequencing (NGS) technology, MetaPanel analyzes a diverse range of genetic material in stool samples, enabling the detection of various potential pathogens, including those not routinely assessed in traditional gastrointestinal panels.

In August 2022, SSI Diagnostica Group (SSID), a Denmark-based in-vitro diagnostics company, completed the acquisition of TechLab for an undisclosed sum. This acquisition is envisioned to broaden SSID's portfolio of infectious disease products and facilitate accelerated growth in the US market. The strategic move brings valuable commercial and manufacturing expertise, particularly in the pivotal US market. TechLab, based in the US, specializes in delivering rapid diagnostic tests for infectious diseases associated with the gastrointestinal and enteric systems.

Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Hologic Inc., bioMerieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, Puritan Medical Products Co. LLC, Cosmo Bio Co. Ltd., R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics

North America was the largest region in the gastrointestinal pathogen testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastrointestinal pathogen testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastrointestinal pathogen testing market consists of revenues earned by entities by providing services, such as molecular testing, culture and sensitivity testing, and rapid diagnostics tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastrointestinal pathogen testing market also includes sales of testing kits, laboratory equipment, and PCR (Polymerase Chain Reaction) machines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastrointestinal Pathogen Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastrointestinal pathogen testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastrointestinal pathogen testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastrointestinal pathogen testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Pathogen Type: Bacteria; Viruses; Parasites
  • 2) By Test Type: Molecular Tests; Culture; Biochemical Tests; Other Test Types
  • 3) By Panel Type: Syndromic Full Multiplex Panels; Other Panel Types
  • 4) By End-User: Hospitals; Diagnostic Laboratories; Point-Of-Care; Other End Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd; Becton Dickinson and Company; Hologic Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gastrointestinal Pathogen Testing Market Characteristics

3. Gastrointestinal Pathogen Testing Market Trends And Strategies

4. Gastrointestinal Pathogen Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Gastrointestinal Pathogen Testing Market Size and Growth

  • 5.1. Global Gastrointestinal Pathogen Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Gastrointestinal Pathogen Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Gastrointestinal Pathogen Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Gastrointestinal Pathogen Testing Market Segmentation

  • 6.1. Global Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bacteria
  • Viruses
  • Parasites
  • 6.2. Global Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Molecular Tests
  • Culture
  • Biochemical Tests
  • Other Test Types
  • 6.3. Global Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Syndromic Full Multiplex Panels
  • Other Panel Types
  • 6.4. Global Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Point-Of-Care
  • Other End Users

7. Gastrointestinal Pathogen Testing Market Regional And Country Analysis

  • 7.1. Global Gastrointestinal Pathogen Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Gastrointestinal Pathogen Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Gastrointestinal Pathogen Testing Market

  • 8.1. Asia-Pacific Gastrointestinal Pathogen Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Gastrointestinal Pathogen Testing Market

  • 9.1. China Gastrointestinal Pathogen Testing Market Overview
  • 9.2. China Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Gastrointestinal Pathogen Testing Market

  • 10.1. India Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Gastrointestinal Pathogen Testing Market

  • 11.1. Japan Gastrointestinal Pathogen Testing Market Overview
  • 11.2. Japan Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Gastrointestinal Pathogen Testing Market

  • 12.1. Australia Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Gastrointestinal Pathogen Testing Market

  • 13.1. Indonesia Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Gastrointestinal Pathogen Testing Market

  • 14.1. South Korea Gastrointestinal Pathogen Testing Market Overview
  • 14.2. South Korea Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Gastrointestinal Pathogen Testing Market

  • 15.1. Western Europe Gastrointestinal Pathogen Testing Market Overview
  • 15.2. Western Europe Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Gastrointestinal Pathogen Testing Market

  • 16.1. UK Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Gastrointestinal Pathogen Testing Market

  • 17.1. Germany Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Gastrointestinal Pathogen Testing Market

  • 18.1. France Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Gastrointestinal Pathogen Testing Market

  • 19.1. Italy Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Gastrointestinal Pathogen Testing Market

  • 20.1. Spain Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Gastrointestinal Pathogen Testing Market

  • 21.1. Eastern Europe Gastrointestinal Pathogen Testing Market Overview
  • 21.2. Eastern Europe Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Gastrointestinal Pathogen Testing Market

  • 22.1. Russia Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Gastrointestinal Pathogen Testing Market

  • 23.1. North America Gastrointestinal Pathogen Testing Market Overview
  • 23.2. North America Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Gastrointestinal Pathogen Testing Market

  • 24.1. USA Gastrointestinal Pathogen Testing Market Overview
  • 24.2. USA Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Gastrointestinal Pathogen Testing Market

  • 25.1. Canada Gastrointestinal Pathogen Testing Market Overview
  • 25.2. Canada Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Gastrointestinal Pathogen Testing Market

  • 26.1. South America Gastrointestinal Pathogen Testing Market Overview
  • 26.2. South America Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Gastrointestinal Pathogen Testing Market

  • 27.1. Brazil Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Gastrointestinal Pathogen Testing Market

  • 28.1. Middle East Gastrointestinal Pathogen Testing Market Overview
  • 28.2. Middle East Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Gastrointestinal Pathogen Testing Market

  • 29.1. Africa Gastrointestinal Pathogen Testing Market Overview
  • 29.2. Africa Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Gastrointestinal Pathogen Testing Market Competitive Landscape And Company Profiles

  • 30.1. Gastrointestinal Pathogen Testing Market Competitive Landscape
  • 30.2. Gastrointestinal Pathogen Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche Ltd
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton Dickinson and Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Hologic Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Gastrointestinal Pathogen Testing Market Other Major And Innovative Companies

  • 31.1. bioMerieux S.A.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. QIAGEN N.V.
  • 31.4. DiaSorin S.p.A.
  • 31.5. Cepheid Inc.
  • 31.6. OraSure Technologies Inc.
  • 31.7. BioFire Diagnostics Inc.
  • 31.8. Luminex Corporation
  • 31.9. Meridian Bioscience Inc.
  • 31.10. Sekisui Diagnostics LLC
  • 31.11. ELITechGroup S.A.S.
  • 31.12. Hardy Diagnostics LLC
  • 31.13. Trinity Biotech plc
  • 31.14. Puritan Medical Products Co. LLC
  • 31.15. Cosmo Bio Co. Ltd.

32. Global Gastrointestinal Pathogen Testing Market Competitive Benchmarking

33. Global Gastrointestinal Pathogen Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Gastrointestinal Pathogen Testing Market

35. Gastrointestinal Pathogen Testing Market Future Outlook and Potential Analysis

  • 35.1 Gastrointestinal Pathogen Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Gastrointestinal Pathogen Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Gastrointestinal Pathogen Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer